Prognostic Impact of Baseline High-Sensitivity C-Reactive Protein in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Based on Body Mass Index
![]() |
Ahmed, Khurshid
(Department of Cardiovascular Medicine, Chonnam National University College of Medicine)
Jeong, Myung-Ho (Department of Cardiovascular Medicine, Chonnam National University College of Medicine) Chakraborty, Rabin (Department of Cardiology, Apollo Gleneagles Hospital) Cho, Kyung-Hoon (Department of Cardiovascular Medicine, Chonnam National University College of Medicine) Sim, Doo-Sun (Department of Cardiovascular Medicine, Chonnam National University College of Medicine) Hong, Young-Joon (Department of Cardiovascular Medicine, Chonnam National University College of Medicine) Ahn, Young-Keun (Department of Cardiovascular Medicine, Chonnam National University College of Medicine) Hachinohe, Daisuke (Department of Cardiovascular Medicine, Chonnam National University College of Medicine) Cho, Myeong-Chan (Department of Cardiology, Chungbuk National University College of Medicine) Kim, Chong-Jin (Department of Cardiovascular Medicine, Kyunghee University College of Medicine) Kim, Young-Jo (Department of Cardiology, Yeungnam University College of Medicine) |
1 | Koenig W, Khuseyinova N, Baumert J, Meisinger C. Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. Clin Chem 2008;54:335-42. DOI ScienceOn |
2 | Marsik C, Kazemi-Shirazi L, Schickbauer T, et al. C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem 2008; 54:343-9. DOI ScienceOn |
3 | Kang WY, Jeong MH, Ahn YK, et al. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in STsegment elevation myocardial infarction. J Cardiol 2010;55:84-91. DOI ScienceOn |
4 | Devaraj S, O'Keefe G, Jialal I. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab 2005;90:4549-54. DOI ScienceOn |
5 | Noh HJ, Kwon NH, Joo SB. Severity of coronary atherosclerosis; influence of mtabolic syndrome risk factor clustering and hs-CRP. Korean Circ J 2006;36:802-8. |
6 | Sim DS, Jeong MH, Kang JC. Current management of acute myocardial infarction: experience from the Korea Acute Myocardial Infarction Registry. J Cardiol 2010;56:1-7. DOI ScienceOn |
7 | Lee KH, Jeong MH, Ahn YK. Sex differences of the clinical characteristics and early management in the Korea Acute Myocardial Infarction Registry. Korean Circulation J 2007;37:64-71. DOI ScienceOn |
8 | Sim DS, Kim JH, Jeong MH. Differences in clinical outcomes between patients with ST-elevation versus non-ST-elevation acute myocardial infarction in Korea. Korean Circ J 2009;39:297-303. DOI ScienceOn |
9 | WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63. DOI ScienceOn |
10 | Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002;144:981-6. DOI ScienceOn |
11 | Kini AS. Coronary angiography, lesion classification and severity assessment. Cardiol Clin 2006;24:153-62, v. DOI ScienceOn |
12 | Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65. DOI ScienceOn |
13 | Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107:391-7. DOI ScienceOn |
14 | Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. DOI ScienceOn |
15 | Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-8. DOI ScienceOn |
16 | Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, Arikan S. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels: is adipocyte size associated with inflammation in adults? J Endocrinol Invest 2007;30:210-4. DOI |
17 | Bastard JP, Maachi M, Van Nhieu JT, et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002;87:2084-9. DOI ScienceOn |
18 | Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 2003;311:372-9. DOI ScienceOn |
19 | Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin- 6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002;105:1890-6. DOI ScienceOn |
20 | Wang CH, Li SH, Weisel RD, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003; 107:1783-90. DOI ScienceOn |
21 | Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282:2131-5. DOI ScienceOn |
22 | Araujo JP, Lourenco P, Azevedo A, et al. Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail 2009;15:256-66. DOI ScienceOn |
23 | De Sutter J, de Buyzere M, Gheeraert P, et al. Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction. Atherosclerosis 2001;157: 189-96. DOI ScienceOn |
24 | Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003;167:73-9. DOI ScienceOn |
25 | Ryu SY, Lee YS, Park J, Kang MG, Kim KS. Relations of plasma highsensitivity C-reactive protein to various cardiovascular risk factors. J Korean Med Sci 2005;20:379-83. DOI ScienceOn |
26 | Bursi F, Weston SA, Killian JM, Gabriel SE, Jacobsen SJ, Roger VL. C-reactive protein and heart failure after myocardial infarction in the community. Am J Med 2007;120:616-22. DOI ScienceOn |
27 | Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, González-Arencibia C. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail 2002;4:331-6. DOI ScienceOn |
28 | Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 2001;37:1284-8. DOI ScienceOn |
29 | Tataru MC, Heinrich J, Junker R, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J 2000;21:1000-8. DOI ScienceOn |
30 | Nissen SE, Tuzcu EM, Schoenhagen P, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005;352:29-38. DOI ScienceOn |
31 | Rao AD, Milbrandt EB. To JUPITER and beyond: statins, inflammation, and primary prevention. Crit Care 2010;14:310. DOI |
32 | De Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982;47:239-43. DOI ScienceOn |
33 | Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial: Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-58 DOI ScienceOn |
![]() |